Skip to main content

01.12.2018 | Hypothesis | Ausgabe 1/2018 Open Access

Cancer Cell International 1/2018

Cancer cells arise from bacteria

Cancer Cell International > Ausgabe 1/2018
Qing-lin Dong, Xiang-ying Xing
bacterial origin of cancer cells
DNA storage bodies
double membrane
double membrane segment
eukaryotic cytoplasm
heterogenous globular body
multifunctional organelle
nascent cancer cells
nuclear envelope
primary cancer cells
polyploidy giant cells
polyploid giant cancer cells
secondary cancer cells


It is believed that cancer cells (PCCs) are altered normal cells formed by cell transformation. Based on this belief, extensive studies have been conducted, while the pathogenetic mechanism of cancer is, still, unclear [1]. Hence, this fundamental belief may be questionable. In the following sections, we (1) analyze the cellular processes of cancer cell formation described in the previous researches, (2) compare the similarities between cancer cell formation and cyanobacterium TDX16’s development and transition [2, 3], and (3) propose BOCC hypothesis.

Cancer cells are “senescence-escaping cells” with unknown origin

Cancer cell formation is a complex event that can hardly be made clear in vivo. Since the landmark experiments showing that the normal cells in cultures gradually transformed into cancer cells [4, 5], in vitro cell transformation become the model experiment method to mimic in vivo cancer cell formation. The following studies manifested that in vitro cell transformation can occur spontaneously [69] or in the presence of physical stimuli [10], chemical carcinogens [11, 12] and viruses [1317] in a similar pattern: the normal cells either completely failed to grow or divided for limited number of generations owing to the finite proliferative lifespan [18] and then became senescent and entered “crisis” [19], consequently most of the cells died, while only rare cells occasionally “escaped” cellular senescence or crisis and survived as the cancer cells, with altered morphology, ultrastructure, chromosomes [6, 2022] and growth behavior properties [23, 24].
Nonetheless, the origin and developmental process of cancer cells are unknown, because cell transformations took a long period of time and the obtained cell cultures were composed of a mixture of small undifferentiated cells, polyploidy (hyperchromatic) giant cells (PGCs), flat multinucleated giant cells and sloughing, differentiating cells [7, 14, 15, 2527], which made it difficult to track the trajectory of cancer cell development. In this case, cancer cells were postulated to be transformed from the normal cells, usually called “transformed cells”.

PCCs/SCCs were formed in but not transformed from the senescent normal cells/PCCs

Recent studies revealed that the senescing normal cells turned into mitotically incapacitated PGCs, in which small nascent PCCs were being formed, and when PGCs burst, a large number of small PCCs were released [2834]. Hence, PCCs are formed in but not transformed from the senescent normal cells. Similarly, new small nascent SCCs were formed in the senescent polyploid giant cancer cells (PGCCs) [32, 3546]. These results demonstrated that PCCs and SCCs formations share a common cellular mechanism.
Nevertheless, the cellular mechanism of how the small active PCCs/SCCs were formed in the senescent unviable PGCs/PGCCs is unclear, and remains a paradox. The common explanation is that small nuclei budded from the large PGCs/PGCCs nuclei, and then became small PCCs/SCCs by re-budding off from PGCs/PGCCs, or via asymmetric cytokinesis of PGCs/PGCCs. However, indeed, nuclear budding and cytokinesis were unachievable in the senescent PGCs/PGCCs, because no energy and membrane sources were available for sustaining such active actions.
Different from the common explanation, one study showed that small SCCs were formed in the nuclei of PGCCs [35]. Similar results were frequently reported in early researches: (1) SCCs-like nuclear inclusions were developed within PGCCs nuclei [47]; and (2) PCCs-like pycnotic cells and nuclear inclusions [48], intranuclear inclusion bodies [27, 49], intranuclear membrane-bound inclusions [23] and “micronuclei” [50] were formed in PGCs nuclei, which increased in number and distributed throughout PGCs after the large nuclei disappeared. As to how the intranuclear PCCs/SCCs were formed, it was speculated that SCCs were probably derived from the ‘coiled bodies’ [35], which were, however, delimited by membranes and thus also SCCs but not the membrane-less coiled bodies [51]. Thus, there must be other precursors from which PCCs/SCCs were formed.
Since the small nascent PCCs/SCCs lack organelles and bear resemblances to the intracellular bacteria [5261], it is likely that the small PCCs/SCCs were developed from the bacteria within PGCs/PGCCs. This notion may be intuitively unacceptable, but actually is possible in theory that eukaryotes originate from prokaryotes and supported by our finding that the cyanobacterium TDX16 (prokaryote) turned into a new alga TDX16-DE (eukaryote) [2, 3].

PCCs/SCCs formation are similar to TDX16 development and transition

Haematococcus pluvialis is a unicellular green alga, which grows well and synthesizes astaxanthin in the conditions of high irradiance and low temperature [62, 63]. Conversely, when cultivated under the adverse conditions of low irradiance and high temperature, the growth of H. pluvialis was inhibited [64]. Light microscopic observation showed that the enlarged H. pluvialis cells were undergoing senescence with no astaxanthin accumulation but chlorophyll reduction (Fig. 1A) and ultimately necrosis: the bloated senescent cell ruptured and liberated a massive blue spheroid consisting of countless small cyanobacterial cells (TDX16) (Fig. 1B). Transmission electron microscope observation revealed that very small premature TDX16 cells with electron dense dot-like heterogenous globular body (HGB) [3] multiplied by asymmetric division within the senescent/necrotic H. pluvialis cell at the expense of the dissolved organelles and cytoplasm (Fig. 2A), and subsequently enlarged into small thylakoid-less TDX16 filling up the cellular space (Fig. 2B) [64]. The liberated TDX16 was light-sensitive and unstable, which changed slowly, maintained prokaryotic state, and displayed different statuses even in the same sporangium in the dim light (Fig. 2C), but turned readily and quickly into a small green alga (TDX16-DE) by de novo organelle biogenesis as light intensity elevated (Fig. 2D) [2, 3]. TDX16-DE is a new species of green alga, containing only a double-envelope-bounded nucleus, a chloroplast, one or more mitochondria and double-membrane-bounded vacuoles, but no other organelles (Fig. 2D) [3]. Sequencing results of 16S rRNA (GenBank KJ599678.2) and Genome (GenBank NDGV00000000) indicate that TDX16 is a cyanobacterium resembling Chroococcidiopsis thermalis, which had acquired 9,017,401 bp DNAs with 10,301 genes from its host H. pluvialis. Thus, the reason for TDX16-to-TDX16-DE transition is the hybridization of the obtained eukaryotic DNA and TDX16’s prokaryotic ones, and expression of the hybrid genome [3].
TDX16’s transition demonstrates that a prokaryotic cyanobacterium can obtain its senescent algal host’s DNA and develop into a new eukaryotic alga. Since bacteria and cyanobacteria are close relatives sharing similar structures and behaviors, it is possible that some bacteria, like TDX16, are capable of prokaryote-to-eukaryote transition under the similar conditions. If so, the bacteria within normal/cancer cells of multicellular eukaryotes may develop into new single-celled eukaryotes: PCCs/SCCs. Consistent with this notion, PCCs/SCCs formation really share striking similarities with TDX16 development and TDX16-to-TDX16-DE transition (Figs. 1, 2):
Similar to TDX16 development, the nascent PCCs/SCCs (1) are formed within PGCs/PGCCs, (2) reproduce by asymmetric division, which is usually interpreted as the unachievable division of PGCs/PGCCs or subnuclei, (3) aggregate into spheroids [28, 31, 33, 39, 4146], and (4) are released after PGCs/PGCCs burst [28, 41].
The newly released/formed PCCs/SCCs are very small and undifferentiated [15, 35, 46, 65, 66] containing only “micronuclei” [27, 35], which are, however, not the real nuclei but the single-membrane-bounded DNA storage bodies (DSBs), similar to HGBs in TDX16 (Fig. 2A, B) [3]. So, just as TDX16, PCCs/SCCs are initially absent of organelles.
Although how and when organelles are developed in the small PCCs/SCCs remain unknown, it is certain that with the enlargement of latter organelles are formed de novo in a way akin to organelle biogenesis in TDX16 that resulted in its transition into eukaryotic TDX16-DE (Fig. 2D) [3].

Presentation of the hypothesis

Based on the above analyses and comparisons, we propose the bacterial origin of cancer cells (BOCC) that PCCs/SCCs arise from bacteria through 8 steps (Fig. 3):
Under the stress of physical, chemical or biological factors, normal cells/PCCs undergo senescence, turn into PGCs/PGCCs with large nuclei and lose the ability to control the intracellular bacteria and keep out the extracellular ones, leading to activation of the former and invasion of the latter (Fig. 3a).
The intracellular bacteria usually reside in PGCs/PGCCs cytoplasm. Occasionally, one or several bacteria intrude into the large PGCs/PGCCs nuclei, take up the active nuclear DNAs (including related proteins) and retain the acquired DNAs in the replicable membrane-delimited DSBs. As such, the DSB-containing bacteria in PGCs/PGCCs turn into the small nascent cancer cells (NCs): PCCs/SCCs (Fig. 3b), which are usually mistaken for “small nuclei” or “micronuclei” in PGCs/PGCCs and “multinucleated giant cells”/“multinucleated giant cancer cells”.
The small NCs reproduce via asymmetric division in PGCs/PGCCs nuclei, some of which penetrate the nuclear envelope (NE) into the cytoplasm (Fig. 3c).
All NCs enter cytoplasm after the rupture of NE, and continue to proliferate at the expense of degraded organelles and cytoplasm. During this process, some NC protrude and escape from the necrotic PGCs/PGCCs (Fig. 3d); while most NCs aggregate into a spheroid, which is liberated after the burst of PGCs/PGCCs (Fig. 3e).
As NC increases in size, DSB disrupts and thus the acquired eukaryotic DNAs and the bacterial DNAs fragment and hybridize into a hybrid genome in a way similar to the genome assembly of TDX16-DE [3] and “chromothripsis” [67]; concurrently, a peripheral double membrane segment (DMS) is synthesized by fusion of the cytoplasmic membrane-derived vesicles (Fig. 3f).
NC further enlarges, DMS extends into a closed double membrane (DM) enclosing the total cytoplasm, and thus gives rise to a single multifunctional organelle (MO). Inside MO, mitochondria are assembled by encapsulating the relevant components (e.g., DNAs) with the double membranes synthesized by fusing the inner DM membrane-derived vesicles; meanwhile, a small opening (O) is formed on DM allowing the selective release of MO matrix (Fig. 3g).
The released MO matrix builds up the eukaryotic cytoplasm (EC), and the newly assembled mitochondria detach from MO into EC; while new mitochondria are developed continuously in MO, resulting in the diminishment of MO (Fig. 3h).
After all mitochondria enter EC, MO dwindles into a nucleus (N), such that NCs develop into large mature PCCs/SCCs (Fig. 3i).
In the way described above, new SCCs can be developed successively from the same or different species of bacteria, which inevitably result in the increased heterogeneity, genetic instability and endless complexity of cancer cells in vivo and in vitro. Hence, PCCs, SCCs and the subsequent new SCCs look superficially like the putative “cancer stem cells” [68] in cancer progression.

Evidences supporting the BOCC hypothesis

There are 10× more bacterial cells than human cells in the human body [69].
Bacteria play a key role in carcinogenesis. Helicobacter pylori is a definite carcinogen for gastric cancer [70]. Many other bacteria are related with various cancers, such as Salmonella typhi [71], Chlamydia pneumoniae [72], Mycoplasma hominis [73], Bacteroides fragilis [74], Streptococcus bovis [75], Escherichia coli [76], Fusobacterium spp. [77]. and Neisseria gonorrhoeae [78].
Like bacteria and single-celled eukaryotes (protists, e.g., yeast), cancer cells can grow in agar medium and form colonies [79], proliferate in the absence of anchorage in vitro [80] and ferment glucose in the absence of oxygen (anaerobic fermentation) with the production of lactic acid [81].
Cancer cell genomes were assembled from DNA fragments all at once in a single catastrophic event (chromothripsis) [67].
Cancer cell genomes contain bacterial DNA [8284].
Genes of ancient and unicellular origin are highly and preferentially expressed during tumorigenesis [85, 86].

Testing the hypothesis

The following BOCC-based predictions can be used for testing the hypothesis:
No bacteria, no cancer. So, after eliminating the intracellular bacteria, normal cells can not “transform” into cancer cells in any conditions.
Testing Inducing the bacteria-containing and bacteria-free normal cells with different carcinogens and infectious agents and tracking their changes.
The “small nuclei” in “multinucleated giant cells”/“multinucleated giant cancer cells” and PGCs/PGCCs as well as the chromothripsis-related “micronuclei” [8789] are the bacteria-derived nascent PCCs/SCCs, containing bacterial and host’s DNAs.
Testing Isolating the “small nuclei” and “micronuclei”, sequencing their DNAs and identifying bacterial DNAs.
The “small nuclei” and “micronuclei” mentioned above have no organelles but DSBs, which enlarge and develop into eukaryotic cancer cells by de novo organelle biogenesis after disruption of DSBs.
Testing Cultivating the isolated “small nuclei” and “micronuclei” and track microscopically the changes of cellular structure.
There is an outer membrane external to the cytoplasmic membrane of “small nuclei”, “micronuclei” and PCCs/SCCs (except those that arose from the cell wall-less bacteria e.g., Mycoplasma), while the cytoplasmic membrane is capable of oxidative phosphorylation and lipid synthesis.
Testing Detecting the outer membrane, and identifying the electron carriers of oxidative phosphorylation and the relevant enzymes in the cytoplasmic membrane.
PCCs/SCCs genomes contain massive hybrid genes with bacterial gene sequences.
Testing Identification of bacterial DNA sequences in PCCs/SCCs genomes.

Implications of the hypothesis

Clarifying the cause and results of cancer

Cancer cell genomes are formed by hybridizing the acquired eukaryotic DNAs and bacterial ones. Such hybridization inevitably result in (1) gene loses, substitution and synthesis, which are usually ascribed to “mutations” (DNA changes), and (2) aneuploidy and karyotypic heterogeneity, which are considered to be the reasons for genome instability. Therefore, genetic changes and instabilities are not the causes, but the consequences of cancer cell development.

Explaining the reason behind the hallmarks of cancer

In the light of BOCC the reason behind the hallmarks of cancer [90, 91] become clear. Cancer cells are new bacteria-derived single-celled eukaryotes formed by expression of the hybrid genomes, which inevitably exhibit the characteristics of protists, e.g., “self-sufficiency”, “replicative immortality”, “invasion and metastasis” and somatic cells, i.e. “angiogenesis”, but evade somatic-cell-targeted controls of “growth suppress” and “apoptosis”. Indeed, “reprogramming energy metabolism” that cancer cells generate energy via ‘‘aerobic glycolysis”, i.e. “Warburg effect” [81], is also a characteristic of protists, because the yeast Saccharomyces cerevisiae produce energy via aerobic fermentation [92] called “Crabtree effect” [93]. As to “evading immune destruction”, the reasons may be that the cancer-causing bacteria have already developed strategies to evade immune system defenses as indicated by their persistence within the host cells, so the bacteria-derived cancer cells acquire the capability to evade immune destruction.

Clarifying the common role of carcinogens, infectious agents and relating factors in carcinogenesis

Cancer can be caused by physical and chemical carcinogens [94], infectious agents [95] including viruses [96], bacteria [70] and parasites [97], and related to the factors of organismal aging [98], immunity [99] and inflammation [100]. It is reasonable that these varied carcinogens, infectious agents and relating factors play or link to a common role in carcinogenesis. Such a common role is unknown, but apparently not mutation, because most of the carcinogens and infectious agents are not mutagenic.
According to BOCC theory, senescence of normal cells is the prerequisite for the formation of bacteria-derived cancer cells. Hence, the common role of carcinogens, infectious agents and relating factors in carcinogenesis is inducing or linked to cellular senescence. In general, carcinogens and infectious agents induce cell senescence by (1) causing cell damage and or more or less DNA changes (physical and chemical carcinogens), (2) integrate DNA into host cell genome to interfere cell metabolic activities (viruses), (3) mechanical irritation (parasites), (4) secreting irritant metabolites (bacteria and parasites), (5) inducing chronic inflammation (physical and chemical carcinogens, bacteria, viruses, and parasites) and (6) interfering or inhibiting host’s immune system resulting in lowered immunity or immunosuppression (physical and chemical carcinogens, bacteria, viruses, and parasites); while organismal aging is associated with immunity declines and thus cellular senescence.

Providing a new rationale and direction for cancer research, prevention and therapy

If confirmed, BOCC theory provides a new rationale for cancer research, and a new direction for cancer prevention and therapy. Eliminating the cancer-causing bacteria in the body with antibiotics or other agents, stopping bacteria’s acquisition and hybridization of host’s DNAs, and developing bacteria-targeted vaccines can prevent cancer and inhibit, to some extent, cancer progression. Identifying the differences between the bacteria-derived cancer cells and normal cells in structure, constitution and metabolism can provide targets for developing drugs and vaccines to eradicate cancer cells in cancer treatment.

Authors’ contributions

The authors make equal contributions for the work. Both authors read and approved the final manuscript.


Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

Not applicable.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.


Self funded by authors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

Cancer Cell International 1/2018 Zur Ausgabe